Use of Melatonin in people with Parkinson’s disease - service improvement audit


By Alison Kearney, Parkinson's Nurse Specialist, York Teaching Hospital NHS Foundation Trust

Poster

Introduction

  • Sleep disturbance in PD is common approximately 70% affected.

  • Associated with poor quality of life

  • Types of sleep disturbance = restless legs, excessive daytime sleepiness REM sleep behaviour disorder

  • NICE guidance “Consider clonazepam or melatonin to treat RBD if a medicines review has addressed possible pharmacological causes” (NICE., 2017)

  • Melatonin has a significant role in the circadian rhythm regulatory function

Currently:

  • Melatonin is being used to treat sleep disorders in the Scarborough/Bridlington region

  • Subjectively reviewed at clinic visits without an objective measure

  • Allowed for community prescription in patient within the East Yorkshire CCG but not for the North Yorkshire region – all of which attend the same PD service coordinated by Scarborough Hospital

Objective

  • To evaluate use of melatonin in patients with PD and associated REM sleep behaviour disorder

  • To objectively quantify effect, allowing for cost analysis of use and standardise protocols for use over the region using PDSS.

  • To ensure every patient does a PDSS before and after starting melatonin

More Parkinson's Academy Sleep Projects

Use of Melatonin in people with Parkinson’s disease - service improvement audit
By Alison Kearney, Parkinson's Nurse Specialist, York Teaching Hospital NHS Foundation Trust
Daytime sleepiness in elderly Parkinson disease patients
By Dr Apurba Koomar Chatterjee, Consultant Physician and Clinical Lead, Royal Berkshire NHS Foundation Trust
Audit of sleep disorder in older PD patients using PDSS
By Dr Sandip Raha, Associate Specialist in Medicine, Cwm Taff Morgannwg university Health Board
'The things you can't get from the books'

Parkinson's Academy, our original and longest running Academy, houses 19 years of inspirational projects, resources, and evidence for improving outcomes for people with Parkinson's. Led by co-founder and educational director Dr Peter Fletcher, the Academy has a truly collegiate feel and prides itself on delivering 'the things you can't get from books' - a practical learning model which inspires all Neurology Academy courses.